
Blue ribbon for prostate cancer awareness and men’s health
Receiving a diagnosis of localized prostate cancer can turn your life upside down in a matter of minutes. For many men, the shock is immediately followed by an overwhelming question: Should I treat my cancer now, or can I safely monitor it without taking unnecessary risks?
On the one hand, active surveillance can often help avoid or delay treatment. On the other, newer focal therapy approaches for prostate cancer, such as HIFU (high-intensity focused ultrasound) and NanoKnife, aim to destroy the tumor while limiting the side effects associated with more aggressive treatments.
So, how can you make an informed decision when you are caught between the fear of cancer progression and the fear of the consequences of treatment?
Cancer is considered localized when it remains confined to the prostate and shows no signs of spread to the lymph nodes, bones, or other organs.
In this situation, the prognosis is generally excellent. However, not all localized prostate cancers behave in the same way:
It is precisely this difference that explains why the same recommendation does not apply to every patient.
Active surveillance for prostate cancer involves closely monitoring the progression of the cancer without immediately undergoing definitive treatment.
Patients generally undergo follow-up that includes:
The goal is simple: to intervene only if the cancer shows signs of progression.
The absence of immediate treatment generally means no hospitalization, no recovery time, and little to no immediate impact on urinary or sexual function.
For some patients, the cancer progresses so slowly that treatment may never become necessary.
Historically, many low-risk cancers were treated aggressively even though they could have been safely monitored.
Despite its benefits, this approach can also present significant psychological challenges. Many men find it difficult to live with the knowledge that cancer is still present in their bodies.
The most common concerns include:
For some patients, this anxiety becomes a major factor in their decision-making process.
Focal therapy is a modern approach that targets only the cancerous area rather than treating the entire prostate.
The principle is similar to that used in other areas of medicine: precisely targeting the lesion while preserving the surrounding healthy tissue.
HIFU uses high-intensity ultrasound waves to precisely target and destroy the tumor.
Potential benefits include:
NanoKnife uses precise electrical pulses to destroy cancer cells while better preserving certain critical anatomical structures.
This technology is particularly interesting when the location of the tumor requires a high degree of precision.
Potential benefits include:
Not all prostate cancers can be treated with HIFU or NanoKnife. Eligibility is assessed based on several factors, including:
Careful patient selection is essential to achieve the best possible outcomes.
Before choosing between active surveillance and focal therapy, it is essential to understand the nature of the cancer as accurately as possible.
This type of biopsy plays a strategic role in that process. The technique combines MRI imaging and ultrasound to target suspicious areas of the prostate with greater precision.
Potential benefits include:
For many men, this step provides the information they need to make a confident and informed decision.
| Criteria | Active Surveillance | HIFU / NanoKnife |
|---|---|---|
| Objective | Monitor progression | Destroy the targeted tumor |
| Immediate treatment | No | Yes |
| Short-term impact on quality of life | Very low | Generally low |
| Risk of cancer-related anxiety | Higher | Often reduced after treatment |
| Recovery time | None | Generally short |
| Preservation of healthy tissue | Complete | High |
| Need for follow-up | Very important | Still necessary |
| Eligibility | Selected low-risk cancers | Carefully selected cases |
The Real Question: What Is Best for You? There is no one-size-fits-all answer. The best option depends on several factors:
A strategy that is appropriate for one patient may be completely unsuitable for another. That is why seeking a specialized second opinion is often one of the most important steps in the decision-making process.
Have you recently been diagnosed with localized prostate cancer and are unsure whether active surveillance or focal therapy is right for you?
At Cliniques Marois, our urologists provide a thorough assessment that includes a review of your medical history, imaging studies, and biopsy results to help determine the most appropriate treatment options for your unique situation.
Don’t make such an important decision alone. Get a Prompt Second Medical Opinion from Our Urologists Today. You may discover that a personalized option exists between anxious waiting and more invasive treatments.
Error: Contact form not found.